Advertisements




Merck Wins Yet Again With New Keytruda Approval

Merck shares were up slightly on Wednesday after the pharma giant gave another key update for its KEYTRUDA line. The firm announced that the U.S. Food and Drug Administration (FDA) has approved........»»

Category: blogSource: 247wallstOct 31st, 2018

Defense Stock Roundup: US-Canada Trade Talk, BA"s Deal Wins, AOBC Earnings in Focus

Zacks.....»»

Category: topSource: redinewsSep 3rd, 2018

Pharma Stock Roundup: JNJ & NVS" Q2 Earnings, FDA Approvals

J&J (JNJ) and Novartis (NVS) kick off earnings for pharma sector on a strong note. FDA approves J&J's latest HIV medicine and line extension of Pfizer's prostate cancer drug. .....»»

Category: personnelSource: nytJul 20th, 2018

Pharma Stock Roundup: Zoetis to Buy Abaxis, NVS Gets FDA Nod for Migraine Drug

Zacks.....»»

Category: topSource: redinewsMay 19th, 2018

Airline Stock Roundup: Earnings Beat at Azul; LUV, JBLU, HA in Focus

Decline in October load factor for carriers like Southwest Airlines (LUV) might lead to capacity-related woes. In the past week, Latin American carrier — Azul S.A. AZUL — reported im.....»»

Category: worldSource: nytNov 14th, 2018

The Daily Biotech Pulse: AbbVie"s Leukemia Drug Trial Meets Endpoint, Denali Strikes Collaboration Deal

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Nov. 1) read more.....»»

Category: blogSource: benzingaNov 1st, 2018

The Daily Biotech Pulse: Gilead"s Q2, Syndax Breast Cancer Drug Setback, Synergy Pharma On Brink Of Default

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Oct. 26) read more.....»»

Category: blogSource: benzingaOct 26th, 2018

GW Pharma stock jumps to record after DEA stance on its CBD drug, cannabis sector lags

Shares of GW Pharmaceuticals PLC surged to a record high Thursday, after the medical-marijuana company announced a new Drug Enforcement Administration stance on its approved drug containing cannabidiol, or CBD......»»

Category: topSource: marketwatchSep 27th, 2018

Teva Wins Approval From FDA for Blockbuster Migraine Drug

InvestorPlace - Stock Market Ne.....»»

Category: topSource: investorplaceSep 19th, 2018

Teva Migraine Drug Ajovy Wins FDA Approval

The stock surged in after-hours trading. Teva Pharmaceutical Industries Ltd. won U.S. regulatory approval to sell a.....»»

Category: europeSource: fortuneSep 15th, 2018

Teva Migraine Drug Wins FDA Approval

The stock surged in after-hours trading. Teva Pharmaceutical Industries Ltd. won U.S. regulatory approval to sell a.....»»

Category: europeSource: fortuneSep 15th, 2018

The Daily Biotech Pulse: FDA Blessings for Merck"s HIV Drug Combo, Veracyte"s Test Gets Medicare Coverage

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on Aug. 30) Acceleron Pharma .....»»

Category: earningsSource: benzingaAug 31st, 2018

5 Drug Stocks to Buy While the Pharma Sector Is on Sale

InvestorPlace - Stock M.....»»

Category: topSource: investorplaceAug 22nd, 2018

How a little 10-employee pharma company hit a whopping $4.4B market cap

Tiny Madrigal’s stock is soaring as it advances an experimental drug targeting NASH......»»

Category: topSource: bizjournalsJul 26th, 2018

Benzinga"s Daily Biotech Pulse: AbbVie Files sNDA For Leukemia Drug, AcelRx Offering, Aurinia Starts Mid-Stage Trial

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on July 11) read more.....»»

Category: blogSource: benzingaJul 12th, 2018

Benzinga"s Daily Biotech Pulse: Titan"s Parkinson"s Disease Drug Implant Trial, Juniper Pharma Sells Itself At 32% Premium

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on July 2) read more.....»»

Category: blogSource: benzingaJul 3rd, 2018

Erytech Pharma (ERYP) Confirms Strategic Focus Of Eryaspase On Solid Tumors And Ceases Development In Acute Lymphoblastic Leukemia - Slideshow

Erytech Pharma (ERYP) Confirms Strategic Focus Of Eryaspase On Solid Tumors And Ceases Development In Acute Lymphoblastic Leukemia - Slideshow.....»»

Category: topSource: seekingalphaJun 26th, 2018

Brainstorm Health: FDA Marijuana-Based Drug Approval, Pharma Innovation, GSK Shingles Vaccine

Brainstorm Health Daily: June 25, 2018 Happy Monday, readers--This is Sy. I was going to focus today’s essay on a striking statement from China on the opioid crisis--spe.....»»

Category: europeSource: fortuneJun 25th, 2018

Airline Stock Roundup: IT Glitch at AAL, ALK & CPA"s May Traffic Reports in Focus

Zacks.....»»

Category: topSource: redinewsJun 20th, 2018

Why Wedbush Sees Albireo More Than Doubling

Albiero Pharma, Inc. (NASDAQ: ALBO) recently received some positive news from the U.S. Food and Drug Administration (FDA) and it could have huge implications for the stock. One analyst actually sees........»»

Category: blogSource: 247wallstJun 13th, 2018